Apple
AAPL
Taylor Morrison Home
TMHC
Tesla
TSLA
4
D.R. Horton
DHI
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.594
- +0.036+6.45%
Trading Mar 27 15:56 ET
175.31MMarket Cap-0.45P/E (TTM)
0.633High0.568Low691.18KVolume0.568Open0.558Pre Close415.49KTurnover0.34%Turnover RatioLossP/E (Static)295.23MShares3.14552wk High0.46P/B119.48MFloat Cap0.48152wk Low--Dividend TTM201.22MShs Float19.840Historical High--Div YieldTTM11.69%Amplitude0.481Historical Low0.601Avg Price1Lot Size
Lyell Immunopharma Key Stats
EPS
According to the latest financial report of Lyell Immunopharma, the latest earnings per share (TTM) for the company is -0.65. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Lyell Immunopharma's free cash flow? The latest report shows it as -47.29M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lyell Immunopharma shows that the company's current ratio is 7.06, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lyell Immunopharma, the quick ratio is 6.89, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Lyell Immunopharma? The latest ROE figure is -42.02%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lyell Immunopharma, the total asset return on investment (ROA) is -34.58%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lyell Immunopharma's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lyell Immunopharma, the net profit margin is -1.74M%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings